γ-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D4 formation in vivo

American Journal of Pathology

Volumn 161, Issue 2, 2002, Pages 481-490

  Han, Bing ^a   Luo, Guoyang ^a   Shi, Zheng Zheng ^a   Barrios, Roberto ^a   Atwood, Donna ^a   Liu, Weili ^a   Habib, Geetha M ^a   Sifers, Richard N ^a   Corry, David B ^a   Lieberman, Michael W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYL LEUKOTRIENASE; GLYCOPROTEIN; LEUKOTRIENE; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; MEMBRANE PROTEIN; PEPTIDOLEUKOTRIENE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL MEMBRANE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LOCALIZATION; FATTY ACID METABOLISM; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE LEVEL;

EID: 0036966306     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64204-6     Document Type: Article

References (38)

1. Henderson Jr WR: The role of leukotrienes in inflammation. Ann Intern Med 1994, 121:684-697
2. Nicosia S, Capra V, Rovati GE: Leukotrienes as mediators of asthma. Pulm Pharmacol Ther 2000, 14:3-19
3. Henderson Jr WR, Lewis DB, Albert RK, Zhang Y, Lamm WJ, Chiang GK, Jones F, Eriksen P, Tien YT, Jonas M, Chi EY: The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 1996, 184:1483-1494
4. 4 synthesis in vivo and attenuation of the acute inflammatory response. Mol Cell Biol 2001, 21:5389-5395
5. Galli SJ: New concepts about the mast cell. N Engl J Med 1993, 328:257-265
6. Williams JD, Czop JK, Austen KF: Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J Immunol 1984, 132:3034-3040
7. Weller PF, Lee CW, Foster DW, Corey EJ, Austen KF, Lewis RA: Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci USA 1983, 80:7626-7630
8. 4 and γ-glutamyl amino acids. Proc Natl Acad Sci USA 1982, 79:1088-1091
9. Lieberman MW, Barrios R, Carter BZ, Habib GM, Lebovitz RM, Rajagopalan S, Sepulveda AR, Shi ZZ, Wan DF: γ-Glutamyl transpeptidase: what does the organization and expression of a multipromoter gene tell us about its functions? Am J Pathol 1995, 147:1175-1185
10. Lynch KR, O'Neill GP, Liu Q, Im D, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, Connolly BM, Bai C, Austin CP, Chateauneuf A, Stocco R, Greig GM, Kargman S, Hooks SB, Hosfield E, Williams Jr DL, Ford-Hutchinson AW, Caskey CT, Evans JF: Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999, 399:789-779
11. Kumlin M, Dahlen SE: Characteristic of formation and further metabolism of leukotrienes in the chopped human lung Biochem Biophys Acta 1990, 1044:201-210
12. Habib GM, Shi ZZ, Cuevas AA, Guo Q, Matzuk MM, Lieberman MW: Leukotriene D4 and cystinyl-bis-glycine metabolism in membrane-bound dipeptidase-deficient mice. Proc Natl Acad Sci USA 1998, 95:4859-4863
13. Maycock AL, Pong SS, Evans JF, Miller DK: Leukotrienes and lipoxygenase: chemical, biochemical and clinical aspect. Leukotrienes and Lipoxygenase: Chemical, Biochemical and Clinical Aspect Edited by J Rokach. Amsterdam, Elsevier, 1989, pp 143-208
14. 4 synthesis deficiency: a member of probably underdiagnosed new group of neurometabolic diseases. Eur J Pediatr 2000, 159:811-818
15. Carter BZ, Wiseman AL, Orkiszewski R, Ballard KD, Ou C, Lieberman MW: Metabolism of leukotriene C4 in γ-glutamyl transpeptidase-deficient mice. J Biol Chem 1997, 272:12305-12310
16. Carter BZ, Shi Z, Barrios R, Lieberman MW: γ-Glutamyl leukotrienase, a γ-glutamyl transpeptidase gene family member, is expressed primarily in spleen. J Biol Chem 1998, 273:28277-28285
17. 4. Eicosanoid and Other Bioactive Lipids in Cancer, Inflammation, and Injury, ed 4. Edited by Honn KV, Marrett LJ, Nigam S, Dennis EA. New York, Kluwer Academic/Plenum Publisher, 1999, pp 301-306
18. Lieberman MW, Wiseman AL, Shi ZZ, Carter BZ, Barrios R, Ou CN, Chevez-Barrios P, Wang Y, Habib GM, Goodman JC, Huang SL, Lebovitz RM, Matzuk MM: Growth retardation and cysteine deficiency in γ-glutamyl transpeptidase-deficient mice. Proc Natl Acad Sci USA 1996, 93:7923-7926
19. Meister A, Larsson A: The Metabolic Basis of Inherited Diseases, ed 7. Edited by CR Scriver, AL Beaudet, WS Sly, D Valle. New York, McGraw-Hill, 1995, pp 1461-1477
20. Lewis RA, Austen KF, Soberman RJ: Leukotriene and other products of the 5-lipoxygenase pathway, biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990, 323:645-655
21. Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, Rennick DM, Locksley RM: Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 1998, 4:344-355
22. Kobata A: Use of endo- and exoglycosidases for structural studies of glycoconjugates Anal Biochem 1997, 100:1-14
23. Trimble RB, Maley F: Optimizing hydrolysis of N-linked high-mannose oligosaccharides by endo-beta-N-acetylglucosaminidase H. Anal Biochem 1984, 141:515-522
24. Tarentino AL, Gomez CM, Plummer Jr TH: Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase F. Biochemistry 1984, 24:4665-4671
25. Meister A, Tate SS, Ross LL: Enzymes of Biological Membranes. Edited by A Martonosi. New York, Plenum Publishing Corp., 1976, pp 315-347
26. Kornfeld R, Kornfeld S: Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985, 54:631-664
27. Meister A, Tate SS, Griffith OW: γ-Glutamyl transpeptidase. Methods Enzymol 1981, 77:237-253
28. Novogrodsky A, Tate SS, Meister A: γ-Glutamyl transpeptidase, a lymphoid cell-surface marker: relationship to blastogenesis, differentiation, and neoplasia Proc Natl Acad Sci USA 1976, 73:2414-2418
29. Vecchi A, Garlanda C, Lampugnani MG, Resnati M, Matteucci C, Stoppacciaro A, Schnurch H, Risau W, Ruco L, Mantovani A: Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur J Cell Biol 1994, 63:247-254
30. Baldwin HS, Shen HM, Yan HC, DeLisser HM, Chung A, Mickanin C, Trask T, Kirschbaum NE, Newman PJ, Albelda SM, Buck CA: Platelet endothelial cell adhesion moleculae-1 (PECAM-1): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 1994, 120:2539-2553
31. Huber M, Keppler D: Inhibition of leukotriene D4 catabolism by D-penicillamine. Eur J Biochem 1987, 167:73-79
32. Frey A: γ-Glutamyl transpeptidase: molecular cloning and structural and functional features of a blood-brain barrier marker protein. The Blood-Brain Barrier. Edited by WM Pardiridge. New York, Raven, 1993, pp 339-369
33. Lawrenson JG, Reid AR, Finn TM, Orte C, Allt G: Cerebral and pial microvessels: differential expression of γ-glutamyl transpeptidase and alkaline phosphatase Anal Embryol 1999, 199:29-34
34. Jankásková B, Lisý, V. Šťastny̌ F: Effect of γ-glutamyl transpeptidase inhibitors on the transport of glutamate into neuronal and glial primary cultures. Int J Dev Neurochem 1992, 10:225-230
35. Adkins JC, Brogden RN: Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma Drugs 1998, 55: 121-144
36. Reiss TF, Sorkness CA, Stricker W, Botto A, Busse WW, Kundu S, Zhang J: Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax 1997, 52: 45-48
37. Kemp JP: Role of leukotriene receptor antagonists in pediatric asthma. Pediatr Pulmonol 2000, 30:177-182
38. Barrios R, Shi ZZ, Wiseman AL, Weity S, Kala G, Bahler AA, Ou CN, Lieberman MW: Oxygen-induced pulmonary injury in γ-glutamyl transpeptidase-deficient mice. Lung 2002, 179:1-12